Between February 18, 2025 and August 18, 2025, Hetalox Spółka z o.o. carried out a project co-financed from European Funds - Startup Booster for Social Impact.

The contribution comes from the Polish Agency for Enterprise Development (PARP), under Priority II of the European Funds for a Modern Economy 2021–2027 (FENG), in accordance with the co-financing agreement no. FENG.02.28-IP.02-0003/23-00.

Tasks:

1. integration of the Hetalox platform for brain MRI scans analysis with AI,
2. evaluation of the tool’s effectiveness,
3. a pilot study with a selected end user in a clinical setting.

Target group:

1. diagnostic imaging centers,
2. medical specialists (radiologists, neurologists),
3. patients with neurodegenerative and demyelinating diseases (e.g., multiple sclerosis),
4. research institutions and commercial partners from the MedTech sector.

Project objectives:

To develop an innovative platform for brain MRI analysis that supports monitoring the progression of neurodegenerative and demyelinating diseases. Hetalox will conduct pilot studies to validate the platform's effectiveness in clinical settings, in collaboration with mentors from the Startup Booster for Social Impact program and the investment fund 24Ventures.

Outcomes and results of the project

1. integration of the Hetalox MRI platform with the technology end user,
2. collection of feedback from users.